We are live on ! Find out more
SCM

Shelton Capital Management Portfolio holdings

AUM $4.57B
1-Year Est. Return 32.26%
This Fund
S&P 500
This Quarter Est. Return
-2.93%
1 Year Est. Return
+32.26%
3 Year Est. Return
+110.31%
5 Year Est. Return
+153.06%
10 Year Est. Return
+630.09%
AUM
$2.1B
AUM Growth
-$120M
Cap. Flow
-$12.8M
Cap. Flow %
-0.61%
Top 10 Hldgs %
29.65%
Holding
741
New
29
Increased
102
Reduced
245
Closed
58

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$4.53M
2
HPQ icon
HP
HPQ
+$4.31M
3
AMZN icon
Amazon
AMZN
+$3.59M
4
JNJ icon
Johnson & Johnson
JNJ
+$3.55M
5
NKE icon
Nike
NKE
+$3.37M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$7.36M
2
AAPL icon
Apple
AAPL
+$6.18M
3
PH icon
Parker-Hannifin
PH
+$4.37M
4
GM icon
General Motors
GM
+$4.21M
5
FISV
Fiserv Inc
FISV
+$3.9M

Sector Composition

Rank Sector Weight
1 Technology 35.9%
2 Consumer Discretionary 12.49%
3 Healthcare 11.09%
4 Communication Services 10.97%
5 Consumer Staples 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIN icon
201
Linde
LIN
$221B
$1.91M 0.09%
7,077
-100
-1% -$28.7K
LUV icon
202
Southwest Airlines
LUV
$22B
$1.91M 0.09%
61,846
BIDU icon
203
Baidu
BIDU
$35.6B
$1.88M 0.09%
15,987
-5,432
-25% -$742K
CRBU icon
204
Caribou Biosciences
CRBU
$169M
$1.82M 0.09%
172,800
-9,200
-5% -$85.7K
ANSS
205
DELISTED
Ansys
ANSS
$1.81M 0.09%
8,148
PLTR icon
206
Palantir
PLTR
$411B
$1.81M 0.09%
222,126
EDIT icon
207
Editas Medicine
EDIT
$436M
$1.78M 0.08%
145,400
-24,600
-14% -$383K
EL icon
208
Estee Lauder
EL
$31.7B
$1.75M 0.08%
8,089
VRSN icon
209
VeriSign
VRSN
$25.6B
$1.72M 0.08%
9,877
NEM icon
210
Newmont
NEM
$124B
$1.66M 0.08%
39,582
-237
-0.6% -$11.1K
PACB icon
211
Pacific Biosciences
PACB
$345M
$1.64M 0.08%
282,100
-47,900
-15% -$275K
ZM icon
212
Zoom
ZM
$30.8B
$1.63M 0.08%
22,131
+1,063
+5% +$101K
MSI icon
213
Motorola Solutions
MSI
$77.7B
$1.61M 0.08%
7,174
-1,900
-21% -$448K
DUK icon
214
Duke Energy
DUK
$96.3B
$1.6M 0.08%
17,213
+8,350
+94% +$897K
AEIS icon
215
Advanced Energy
AEIS
$13.5B
$1.57M 0.07%
20,272
-1,100
-5% -$94.4K
PKG icon
216
Packaging Corp of America
PKG
$22.8B
$1.53M 0.07%
13,651
ALGN icon
217
Align Technology
ALGN
$12.4B
$1.52M 0.07%
7,331
DE icon
218
Deere & Co
DE
$167B
$1.49M 0.07%
4,467
-839
-16% -$287K
C icon
219
Citigroup
C
$231B
$1.47M 0.07%
35,163
-603
-2% -$29.8K
RUN icon
220
Sunrun
RUN
$2.37B
$1.44M 0.07%
52,014
-6,900
-12% -$215K
NTES icon
221
NetEase
NTES
$79.5B
$1.43M 0.07%
18,843
-2,373
-11% -$209K
CL icon
222
Colgate-Palmolive
CL
$73.6B
$1.4M 0.07%
19,882
+1,848
+10% +$145K
INFY icon
223
Infosys
INFY
$49.7B
$1.36M 0.06%
79,930
-467
-0.6% -$8.73K
BAX icon
224
Baxter International
BAX
$13.9B
$1.34M 0.06%
24,872
-1,200
-5% -$72.2K
SWKS icon
225
Skyworks Solutions
SWKS
$10.5B
$1.32M 0.06%
15,443

Similar funds

Shelton Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Shelton Capital Management held 741 positions worth $2.1B, down 5.4% from $2.22B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Shelton Capital Management's Q3 2022 filing shows 29 new, 102 increased, 245 reduced and 58 closed positions. Its largest new stake was Healthcare Realty: 19,987 shares worth $417K. The largest sale was Gilead Sciences, an estimated $7.36M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Shelton Capital Management's largest Q3 2022 buy was Healthcare Realty: 19,987 shares worth $417K.
  • Shelton Capital Management added most to PayPal in Q3 2022, an estimated $4.53M increase.
  • Shelton Capital Management's biggest Q3 2022 reduction was Gilead Sciences, cutting an estimated $7.36M.
  • Shelton Capital Management fully exited Parker-Hannifin in Q3 2022, selling an estimated $4.37M.
  • Shelton Capital Management's ten largest holdings make up 30% of its $2.1B portfolio in Q3 2022.
  • Shelton Capital Management opened 29 new positions and closed 58 in Q3 2022.
  • Shelton Capital Management's portfolio value fell 5.4% quarter-over-quarter to $2.1B.

Based on Shelton Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.